Sees Q3 adjusted EBTIDA $31M-$34M
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLBT:
- CLBT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cellebrite announces U.S. DOJ to sponsor platform for FedRAMP ATO
- 3 Best Stocks to Buy Now, 7/10/2025, According to Top Analysts
- Cellebrite DI: Strategic Leadership Changes and Positive Outlook Justify Buy Rating
- Cellebrite Appoints David Barter as New CFO